Albendazole

Modify Date: 2024-01-02 16:05:41

Albendazole Structure
Albendazole structure
Common Name Albendazole
CAS Number 54965-21-8 Molecular Weight 265.331
Density 1.3±0.1 g/cm3 Boiling Point N/A
Molecular Formula C12H15N3O2S Melting Point 207-211°C(分解)
MSDS Chinese USA Flash Point N/A
Symbol GHS08
GHS08
Signal Word Warning

 Use of Albendazole


Albendazole is a member of the benzimidazole compounds used as a drug indicated for the treatment of a variety of worm infestations.Target: AntiparasiticAlbendazole, marketed as Albenza (United States), Eskazole, Zentel, Andazol and Alworm, is a benzimidazole drug used for the treatment of a variety of parasitic worm infestations. Although this use is widespread in the United States, the U.S. Food and Drug Administration (FDA) has not approved albendazole for this indication. It is marketed by Amedra Pharmaceuticals. Albendazole was first discovered at the SmithKline Animal Health Laboratories in 1972. It is a broad spectrum anthelmintic, effective against roundworms, tapeworms, and flukes of domestic animals and humans.Albendazole has been used as an anthelmintic and for control of flukes in a variety of animal species, including cattle, sheep, goats, swine, camels, dogs, cats, elephants, poultry and others. In many countries, it is very commonly used for ruminant livestock. For use in livestock, albendazole is marketed by Zoetis (formerly Pfizer Animal Health) in numerous countries (including the United States and Canada) as Valbazen in oral suspension and paste formulations; by Interchemie in the Netherlands and elsewhere as Albenol-100; by Channelle Animal Health Ltd. in the United Kingdom as Albex; by Ravensdown in New Zealand as Albendazole; etc. Although most formulations are administered orally, Ricomax (ricobendazole, or albendazole sulfoxide) is administered by subcutaneous injection.

 Names

Name albendazole
Synonym More Synonyms

 Albendazole Biological Activity

Description Albendazole is a member of the benzimidazole compounds used as a drug indicated for the treatment of a variety of worm infestations.Target: AntiparasiticAlbendazole, marketed as Albenza (United States), Eskazole, Zentel, Andazol and Alworm, is a benzimidazole drug used for the treatment of a variety of parasitic worm infestations. Although this use is widespread in the United States, the U.S. Food and Drug Administration (FDA) has not approved albendazole for this indication. It is marketed by Amedra Pharmaceuticals. Albendazole was first discovered at the SmithKline Animal Health Laboratories in 1972. It is a broad spectrum anthelmintic, effective against roundworms, tapeworms, and flukes of domestic animals and humans.Albendazole has been used as an anthelmintic and for control of flukes in a variety of animal species, including cattle, sheep, goats, swine, camels, dogs, cats, elephants, poultry and others. In many countries, it is very commonly used for ruminant livestock. For use in livestock, albendazole is marketed by Zoetis (formerly Pfizer Animal Health) in numerous countries (including the United States and Canada) as Valbazen in oral suspension and paste formulations; by Interchemie in the Netherlands and elsewhere as Albenol-100; by Channelle Animal Health Ltd. in the United Kingdom as Albex; by Ravensdown in New Zealand as Albendazole; etc. Although most formulations are administered orally, Ricomax (ricobendazole, or albendazole sulfoxide) is administered by subcutaneous injection.
Related Catalog
References

[1]. Theodorides VJ, et al. Anthelmintic activity of albendazole against liver flukes, tapeworms., lung and gastrointestinal roundworms. Experientia. 1976 Jun 15;32(6):702-3.

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Melting Point 207-211°C(分解)
Molecular Formula C12H15N3O2S
Molecular Weight 265.331
Exact Mass 265.088501
PSA 92.31000
LogP 3.07
Index of Refraction 1.634
Storage condition 0-6°C

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
FD1100000
CHEMICAL NAME :
Carbamic acid, (5-(propylthio)-1H-benzimidazol-2-yl)-, methyl ester
CAS REGISTRY NUMBER :
54965-21-8
LAST UPDATED :
199806
DATA ITEMS CITED :
10
MOLECULAR FORMULA :
C12-H15-N3-O2-S
MOLECULAR WEIGHT :
265.36
WISWESSER LINE NOTATION :
T56 BM DNJ CMVO1 GS3

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
265 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - hamster
DOSE/DURATION :
>10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
71 mg/kg
SEX/DURATION :
female 8-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
85 mg/kg
SEX/DURATION :
female 8-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
30 mg/kg
SEX/DURATION :
female 10-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
60 mg/kg
SEX/DURATION :
female 10-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
20 mg/kg
SEX/DURATION :
female 17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)

MUTATION DATA

TYPE OF TEST :
Sex chromosome loss and nondisjunction
TEST SYSTEM :
Yeast - Saccharomyces cerevisiae
DOSE/DURATION :
20 mg/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 343,185,1995

 Safety Information

Symbol GHS08
GHS08
Signal Word Warning
Hazard Statements H361-H373
Precautionary Statements P281
Target Organs Blood
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes T
Risk Phrases R61:May cause harm to the unborn child. R36/37/38:Irritating to eyes, respiratory system and skin .
Safety Phrases S53-S45-S37/39-S26
RIDADR NONH for all modes of transport
WGK Germany 2
RTECS FD1100000
HS Code 3004909090

 Synthetic Route

~%

Albendazole Structure

Albendazole

CAS#:54965-21-8

Literature: SEQUENT SCIENTIFIC LIMITED; Rane, Ramkrishna Appaji; Naithani, Sushil; Natikar, Rajendra Devendra; Verma, Sudhakar; Arulmoli, Thangavel Patent: US2013/303782 A1, 2013 ; Location in patent: Paragraph 0031 ;

~%

Albendazole Structure

Albendazole

CAS#:54965-21-8

Literature: US4368328 A1, ;

~30%

Albendazole Structure

Albendazole

CAS#:54965-21-8

Literature: Hazelton; Iddon; Suschitzky; Woolley Tetrahedron, 1995 , vol. 51, # 39 p. 10771 - 10794

~%

Albendazole Structure

Albendazole

CAS#:54965-21-8

Literature: WO2012/70069 A2, ;

~%

Albendazole Structure

Albendazole

CAS#:54965-21-8

Literature: WO2012/70069 A2, ;

~%

Albendazole Structure

Albendazole

CAS#:54965-21-8

Literature: WO2012/70069 A2, ;

~43%

Albendazole Structure

Albendazole

CAS#:54965-21-8

Literature: Hazelton; Iddon; Suschitzky; Woolley Tetrahedron, 1995 , vol. 51, # 39 p. 10771 - 10794

~29%

Albendazole Structure

Albendazole

CAS#:54965-21-8

Literature: Hazelton; Iddon; Suschitzky; Woolley Tetrahedron, 1995 , vol. 51, # 39 p. 10771 - 10794

~%

Albendazole Structure

Albendazole

CAS#:54965-21-8

Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 11, # 11 p. 1359 - 1362

 Customs

HS Code 2933990013
Summary 2933990013 6-(3,5-dichloro-4-methylphenyl)pyridazin-3(2h)-one。supervision conditions:s(import or export registration certificate for pesticides)。VAT:17.0%。tax rebate rate:9.0%。MFN tarrif:6.5%。general tariff:20.0%

 Articles124

More Articles
Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing.

Nat. Commun. 6 , 6410, (2015)

In this study, we show that several microtubule-destabilizing agents used for decades for treatment of cancer and other diseases also sensitize cancer cells to oncolytic rhabdoviruses and improve ther...

Phenotypic and genotypic characterisation of Haemonchus spp. and other gastrointestinal nematodes resistant to benzimidazole in infected calves from the tropical regions of Campeche State, Mexico.

Vet. Parasitol. 205(1-2) , 246-54, (2014)

The aim of this study was to identify the presence of anthelmintic resistance to benzimidazole (BZ) in gastrointestinal nematodes (GIN) from naturally infected calves in the tropical regions of Campec...

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chem. Res. Toxicol. 23 , 171-83, (2010)

Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental...

 Synonyms

Carbamic acid, N-[5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
Methyl hydrogen [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbonimidate
SKF62979
Methanol, 1-methoxy-1-[[6-(propylthio)-1H-benzimidazol-2-yl]imino]-, (E)-
Bilutac
MFCD00083232
ALBEN
Atasol
carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
SK&F-62979
ZENTEL
SK&F 62979
ALBENZA
EINECS 259-414-7
methyl-5-propylthio-2-benzimidazole carbamate
Bruzol
methyl N-[5-(propylthio)-1H-benzimidazol-2-yl]carbamate
Albendazole
ZEBEN
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl 5-(propylthio)benzimidazol-2-ylcarbamate
5-propylthio-2-carbomethoxyaminobenzimidazole
Methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylsulfanyl)-1H-1,3-benzimidazol-2-yl]carbamate
Monil
SK&F62979
Top Suppliers:I want be here






Get all suppliers and price by the below link:

Albendazole suppliers


Price: $66/10mM*1mLinDMSO

Reference only. check more Albendazole price